V
72
-4
LB
60
4
FLR
56
-2
BF.B
33
-4
RSG
76
2
LH
45
-3
RIG
55
-6
CMS
64
4
SO
62
3
WBA
51
-3
ALLE
39
-2
MMC
67
2
HSIC
60
-2
GOOG
57
2
PYPL
56
-4
AVB
67
2
PPL
59
5
GWW
76
2
SRE
45
-9
DLTR
40
-2
V
72
-4
LB
60
4
FLR
56
-2
BF.B
33
-4
RSG
76
2
LH
45
-3
RIG
55
-6
CMS
64
4
SO
62
3
WBA
51
-3
ALLE
39
-2
MMC
67
2
HSIC
60
-2
GOOG
57
2
PYPL
56
-4
AVB
67
2
PPL
59
5
GWW
76
2
SRE
45
-9
DLTR
40
-2
Financhill
Back

Novo Nordisk AS Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
42

NVO
Novo Nordisk AS

Last Price:
106.12
Seasonality Move:
9.67%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Sell
42
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $106.13. The Score for NVO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $106.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.12 Sell
Relative Strength Index (14 RSI): 44.39 Sell
Chaikin Money Flow: -3332086 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.84 - 112.22) Sell
Bollinger Bands (100): (112.38 - 135.68) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.48 Buy
20-day SMA: 106.67 Sell
50-day SMA: 114.31 Sell
200-day SMA: 127.68 Sell
8-day EMA: 104.78 Buy
20-day EMA: 107 Sell
50-day EMA: 113.65 Sell
200-day EMA: 120.19 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.73 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):